• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
Morning Session
 
FDA
  
FDA Presentations, Tivozanib Capsules, for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (PDF – 654KB)
 
 
AVEO Pharmaceuticals, Inc.
 
AVEO Presentations, Tivozanib Capsules, for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (PDF – 2.83MB)
 
 
Afternoon Session
 
FDA
 
FDA Presentations, Melblez Kit, for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (PDF – 410KB)
 
 
Delcath Systems, Inc.
 
Delcath Presentations, Melblez Kit, for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (PDF – 2.37MB)